当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3525309
自主品牌
已选条件
-
T77046Ivonescimab；化合物 IvonescimabIvonescimab
Ivonescimab (AK112) is a PD-1/VEGF bispecific antibody, utilized in cancer research [1] [2] [3].
价 格：￥电议型 号：T77046产 地：中国大陆
-
T77045Itepekimab；单抗ItepekimabREGN-3500|||SAR-440340；REGN-3500|||SAR-440340
Itepekimab (REGN-3500) is a potent monoclonal antibody against IL-33.Itepekimab reduces airway inflammation and associated tissue damage in in vivo experiments and can be used to study asthma.
价 格：￥电议型 号：T77045产 地：中国大陆
-
T77044Istiratumab；化合物 IstiratumabIstiratumab
Istiratumab (M-6495), a bispecific monoclonal antibody, targets IGF-1R and ErbB3 receptors and facilitates their degradation via the proteasome pathway, offering potential for cancer research [1] [2] [3].
价 格：￥电议型 号：T77044产 地：中国大陆
-
T77043Iscalimab；化合物 IscalimabIscalimab
Iscalimab (CFZ-533), a non-depleting IgG1 monoclonal antibody that targets CD40 with a dissociation constant (K D) of 0.3 nM, is utilized in the research of Graves´ hyperthyroidism and autoimmune diseases [1] [2] [3].
价 格：￥电议型 号：T77043产 地：中国大陆
-
T77042Aducanumab；阿杜那单抗BIIB037；BIIB037
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer´s disease (AD).
价 格：￥电议型 号：T77042产 地：中国大陆
-
T77041Iratumumab；化合物 IratumumabIratumumab
Iratumumab (MDX-060), a human anti-CD30 IgG1κ monoclonal antibody, inhibits the growth of CD30-expressing tumor cells and is utilized in the research of Hodgkin´s lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1].
价 格：￥电议型 号：T77041产 地：中国大陆
-
T77040Iparomlimab；化合物 IparomlimabIparomlimab
Iparomlimab, an IgG4κ anti-human PD-1/CD279/PDCD1 antibody, additionally binds to the human monoclonal PSB103 γ4-chain, forming a dimer through disulfide linkage with the human monoclonal PSB103 κ-chain. It is utilized in oncology research [1].
价 格：￥电议型 号：T77040产 地：中国大陆
-
T77036Inolimomab；化合物 InolimomabInolimomab
Inolimomab, an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody, has demonstrated potential to enhance survival rates in preliminary studies addressing acute graft-versus-host disease (aGVHD) [1] [2].
价 格：￥电议型 号：T77036产 地：中国大陆
-
T77035Inezetamab；化合物 InezetamabInezetamab
Inezetamab is a bispecific anti- CD40 and anti- MSLN IgG1 monoclonal antibody [1] .
价 格：￥电议型 号：T77035产 地：中国大陆
-
T77033Imvotamab；化合物 ImvotamabImvotamab
Imvotamab (IGM-2323), a CD20xCD3 bispecific IGM antibody featuring a dual-action mechanism, promotes physiological T cell activation to avoid both over-stimulation and immune function down-regulation. This compound is under development for addressing B-cell malignant tumors, including multiple myeloma (MM) and non-Hodgkin´s lymphoma (NHL) [1] [2] [3] [4].
价 格：￥电议型 号：T77033产 地：中国大陆
-
T77032Imsidolimab；化合物 ImsidolimabImsidolimab
Imsidolimab (ANB 019), a high-affinity, humanized monoclonal antibody targeting IL-36R, antagonizes IL-36 cytokine signal transduction, showing potential in treating generalized pustular psoriasis (GPP) and other inflammatory skin diseases [1] [2].
价 格：￥电议型 号：T77032产 地：中国大陆
-
T77031Ifabotuzumab；化合物 IfabotuzumabIfabotuzumab
Ifabotuzumab (KB004), an IgG1κ antibody, specifically binds to EphA3 (K D =610 pM), inducing tumor cell apoptosis, activating antibody-dependent cell-mediated cytotoxicity (ADCC), and damaging tumor vasculature. Additionally, Ifabotuzumab effectively reduces CCR10+ cells in human idiopathic pulmonary fibrosis (IPF) and ameliorates pulmonary fibrosis, demonstrating its therapeutic potential [1] [2].
价 格：￥电议型 号：T77031产 地：中国大陆
-
T77030Gumokimab；化合物 GumokimabGumokimab
Gumokimab (AK 111), a monoclonal antibody, targets IL-17A and is utilized in researching psoriasis and ankylosing spondylitis. It competitively inhibits the interaction between human IL-17A and its receptor, IL-17R.
价 格：￥电议型 号：T77030产 地：中国大陆
-
T77029Gremubamab；化合物 GremubamabGremubamab
Gremubamab (MEDI3902), a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody, specifically targets and binds to the Pseudomonas aeruginosa PcrV protein and Psl exopolysaccharide. It shows promise for the study of Pseudomonas aeruginosa infections [1] [2].
价 格：￥电议型 号：T77029产 地：中国大陆
-
T77028Gosuranemab；化合物 GosuranemabGosuranemab
Gosuranemab (BMS-986168), a humanized IgG4 anti-tau monoclonal antibody, specifically targets human N-terminal tau residues 15-22. It holds potential for Alzheimer’s disease (AD) research [1] [2].
价 格：￥电议型 号：T77028产 地：中国大陆
-
T77027Gontivimab；化合物 GontivimabGontivimab
Gontivimab (ALX-0171; VR-465), a potent anti-RSV prefusion F protein nanobody, exhibits antiviral activity by reducing the RSV load in the nose and lung, with a dissociation constant (K D) of 0.113 nM [1].
价 格：￥电议型 号：T77027产 地：中国大陆
-
T77025Gimsilumab；化合物 GimsilumabGimsilumab
Gimsilumab (MORAb-022), a humanized anti-GM-CSF monoclonal antibody, shows promise in the research of COVID-19 and rheumatoid arthritis (RA) [1] [2].
价 格：￥电议型 号：T77025产 地：中国大陆
-
T77024Gilvetmab；化合物 GilvetmabGilvetmab
Gilvetmab, a potent caninized anti-PD-1 monoclonal antibody, effectively inhibits the interaction between PD-1 and its ligand PDL-1 [1].
价 格：￥电议型 号：T77024产 地：中国大陆
-
T77023Geptanolimab；化合物 GeptanolimabGeptanolimab
Geptanolimab (CBT-501), a humanized IgG4κ monoclonal antibody targeting PD-1 (Programmed Death-1), functions by competitively inhibiting the interaction between PD-L1/L2 and PD-1, thereby possessing potential use in cancer research [1].
价 格：￥电议型 号：T77023产 地：中国大陆
-
T77022Gefurulimab；化合物 GefurulimabGefurulimab
Gefurulimab (ALXN-1720) is a bispecific antibody derived from humans, targeting complement C5 and albumin. It specifically binds to C5, inhibiting its activation [1].
价 格：￥电议型 号：T77022产 地：中国大陆
